Nonmyeloablative allogeneic stem cell transplant for the treatment of hematologic disorders
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Granulocyte colony-stimulating factors (Primary) ; Ciclosporin; Cyclophosphamide; Fludarabine; Methotrexate
- Indications Acute myeloid leukaemia; Aplastic anaemia; Chronic lymphocytic leukaemia; Graft-versus-host disease; Haematological disorders; Hodgkin's disease; Multiple myeloma; Myelodysplastic syndromes; Myeloproliferative disorders; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Acronyms MINI-HEME
- 05 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Apr 2008 New trial record.